Heart failure & cardiomyopathies
Advanced Heart Failure Characteristics and Outcomes in Commercially Insured U.S. Adults
Authors' conclusion
In U.S. adults with advanced HF, variation in outcomes and use of advanced therapies exist by age, sex, and race/ethnicity.
Study context
- Population
- Commercially insured US adults with advanced heart failure (HF) (2 HF hospitalizations plus 1 additional sign of advanced HF in 12 months), OptumLabs Data Warehouse, 2009–2019
- Participants
- 60,197 participants
- Outcome
- Survival with advanced HF
Methodological detailsadministrative claims database
- Administrative claims database
Main finding
As reported in the abstract
- Median survival
- 2.0 years (IQR: 0.4-5.5 years)
- Adjusted mortality higher in older, male, non-Hispanic White and rural patients
- P < 0.05 for all
Observational data: associations, not effects.
Further findings
Baseline characteristics
- Mean age
- 73 years
- Men
- 51.5%
- Non-Hispanic White
- 64.3%
- Asian
- 1.9%
- Black
- 21.2%
- Hispanic
- 8.2%
Use of advanced therapies
- Advanced therapies used less in older patients and women
- P < 0.05 for both
- Black vs White patients: more likely to be treated with LV assist device
- P = 0.010
- Black vs White patients: less likely to receive heart transplant
- P = 0.034
Original publication
Advanced Heart Failure Characteristics and Outcomes in Commercially Insured U.S. Adults. JACC Heart Fail. Published 16 August 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →